UNICYCIVE THERAPEUTICS, INC. Increase (Decrease) in Deferred Charges
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Increase (Decrease) in Deferred Charges of $103.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2022-08-15
- UNICYCIVE THERAPEUTICS, INC. increase (decrease) in deferred charges for the quarter ending 2020-12-31 was $25.00K.
- UNICYCIVE THERAPEUTICS, INC. increase (decrease) in deferred charges for fiscal 2020 was $117.00K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2021-06-30 | $103.00K 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $117.00K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $92.00K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |